WILHELMUS CM GROENHUYSEN Insider Trading $NVCR NovoCure Ltd
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for WILHELMUS CM GROENHUYSEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of WILHELMUS CM GROENHUYSEN. WILHELMUS CM GROENHUYSEN is Director in NAVTEQ CORP ($NVT) and Director in OptiNose, Inc. ($OPTN) and CFO in NovoCure Ltd ($NVCR) and Chief Financial Officer in Novocure Ltd ($NVCR) and Chief Operating Officer in NovoCure Ltd ($NVCR).
WILHELMUS CM GROENHUYSEN in NovoCure Ltd
Trading Symbol: NVCRIndustry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of WILHELMUS CM GROENHUYSEN: Chief Operating Officer, CFO, Chief Financial Officer
Holdings: 150,014 shares
Current Value: $1,020,095
Latest Transaction: Apr 08 2021
$NVCR Market Capitalization: $581.43M
$NVCR Previous Close: $6.80
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of WILHELMUS CM GROENHUYSEN in NovoCure Ltd
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, NVT, NVCR, OPTN
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 08 2021 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 72.22 | 3,670 | 265,029 | 150,014 | 153.7 K to 150 K (-2.39 %) |
Mar 10 2021 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 130.81 | 3,004 | 392,941 | 153,684 | 156.7 K to 153.7 K (-1.92 %) |
Mar 08 2021 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 137.55 | 3,854 | 530,133 | 156,688 | 160.5 K to 156.7 K (-2.40 %) |
Mar 04 2021 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Option Exercise | A | 153.09 | 23,004 | 3,521,682 | 23,004 | |
Mar 04 2021 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Grant | A | 0.00 | 12,519 | 0 | 160,542 | 148 K to 160.5 K (+8.46 %) |
Mar 04 2021 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 152.05 | 2,392 | 363,711 | 148,023 | 150.4 K to 148 K (-1.59 %) |
Mar 02 2021 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Option Exercise | M | 0.00 | 7,715 | 0 | 0 | |
Mar 02 2021 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Buy | M | 149.10 | 7,715 | 1,150,307 | 150,415 | 142.7 K to 150.4 K (+5.41 %) |
Jan 08 2021 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Grant | A | 50.67 | 93 | 4,712 | 142,700 | 142.6 K to 142.7 K (+0.07 %) |
Sep 21 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Option Exercise | M | 7.48 | 8,262 | 61,800 | 0 | |
Sep 21 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 110.89 | 200 | 22,177 | 142,607 | 142.8 K to 142.6 K (-0.14 %) |
Sep 21 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 110.24 | 1,813 | 199,865 | 142,807 | 144.6 K to 142.8 K (-1.25 %) |
Sep 21 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 109.23 | 3,536 | 386,223 | 144,620 | 148.2 K to 144.6 K (-2.39 %) |
Sep 21 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 108.49 | 2,513 | 272,645 | 148,156 | 150.7 K to 148.2 K (-1.67 %) |
Sep 21 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 106.92 | 200 | 21,383 | 150,669 | 150.9 K to 150.7 K (-0.13 %) |
Sep 21 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Buy | M | 7.48 | 8,262 | 61,800 | 150,869 | 142.6 K to 150.9 K (+5.79 %) |
Sep 18 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Option Exercise | M | 7.48 | 12,500 | 93,500 | 8,262 | |
Sep 18 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Option Exercise | M | 7.48 | 12,500 | 93,500 | 20,762 | |
Sep 18 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Option Exercise | M | 7.03 | 7,579 | 53,280 | 0 | |
Sep 18 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Option Exercise | M | 7.03 | 1,933 | 13,589 | 0 | |
Sep 18 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 110.52 | 100 | 11,052 | 142,607 | 142.7 K to 142.6 K (-0.07 %) |
Sep 18 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 109.81 | 1,500 | 164,708 | 142,707 | 144.2 K to 142.7 K (-1.04 %) |
Sep 18 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 108.79 | 7,868 | 855,960 | 144,207 | 152.1 K to 144.2 K (-5.17 %) |
Sep 18 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 107.94 | 2,232 | 240,911 | 152,075 | 154.3 K to 152.1 K (-1.45 %) |
Sep 18 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 106.68 | 500 | 53,341 | 154,307 | 154.8 K to 154.3 K (-0.32 %) |
Sep 18 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 105.28 | 300 | 31,585 | 154,807 | 155.1 K to 154.8 K (-0.19 %) |
Sep 18 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Buy | M | 7.48 | 12,500 | 93,500 | 155,107 | 142.6 K to 155.1 K (+8.77 %) |
Sep 18 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 109.54 | 600 | 65,725 | 142,607 | 143.2 K to 142.6 K (-0.42 %) |
Sep 18 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 108.71 | 1,700 | 184,805 | 143,207 | 144.9 K to 143.2 K (-1.17 %) |
Sep 18 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 107.66 | 5,123 | 551,558 | 144,907 | 150 K to 144.9 K (-3.41 %) |
Sep 18 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 106.67 | 3,077 | 328,224 | 150,030 | 153.1 K to 150 K (-2.01 %) |
Sep 18 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 105.80 | 2,000 | 211,600 | 153,107 | 155.1 K to 153.1 K (-1.29 %) |
Sep 18 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Buy | M | 7.48 | 12,500 | 93,500 | 155,107 | 142.6 K to 155.1 K (+8.77 %) |
Sep 18 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 109.55 | 400 | 43,822 | 142,607 | 143 K to 142.6 K (-0.28 %) |
Sep 18 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 108.57 | 1,000 | 108,569 | 143,007 | 144 K to 143 K (-0.69 %) |
Sep 18 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 107.65 | 3,279 | 352,978 | 144,007 | 147.3 K to 144 K (-2.23 %) |
Sep 18 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 106.55 | 2,100 | 223,753 | 147,286 | 149.4 K to 147.3 K (-1.41 %) |
Sep 18 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 105.62 | 800 | 84,493 | 149,386 | 150.2 K to 149.4 K (-0.53 %) |
Sep 18 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Buy | M | 7.03 | 7,579 | 53,280 | 150,186 | 142.6 K to 150.2 K (+5.31 %) |
Sep 18 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 109.16 | 200 | 21,831 | 142,607 | 142.8 K to 142.6 K (-0.14 %) |
Sep 18 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 107.97 | 600 | 64,784 | 142,807 | 143.4 K to 142.8 K (-0.42 %) |
Sep 18 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 107.18 | 633 | 67,847 | 143,407 | 144 K to 143.4 K (-0.44 %) |
Sep 18 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 106.05 | 500 | 53,026 | 144,040 | 144.5 K to 144 K (-0.35 %) |
Sep 18 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Buy | M | 7.03 | 1,933 | 13,589 | 144,540 | 142.6 K to 144.5 K (+1.36 %) |
Sep 16 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Option Exercise | M | 7.03 | 12,500 | 87,875 | 7,579 | |
Sep 16 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Option Exercise | M | 7.48 | 13,368 | 99,993 | 0 | |
Sep 16 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Option Exercise | M | 7.03 | 12,500 | 87,875 | 1,933 | |
Sep 16 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Option Exercise | M | 7.48 | 12,500 | 93,500 | 33,262 | |
Sep 16 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Option Exercise | M | 7.03 | 12,500 | 87,875 | 14,433 | |
Sep 16 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Option Exercise | M | 7.03 | 12,500 | 87,875 | 20,079 | |
Sep 16 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 106.02 | 2,334 | 247,444 | 142,607 | 144.9 K to 142.6 K (-1.61 %) |
Sep 16 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 104.69 | 10,166 | 1,064,228 | 144,941 | 155.1 K to 144.9 K (-6.55 %) |
Sep 16 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Buy | M | 7.48 | 12,500 | 93,500 | 155,107 | 142.6 K to 155.1 K (+8.77 %) |
Sep 16 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 104.45 | 13,368 | 1,396,288 | 142,607 | 156 K to 142.6 K (-8.57 %) |
Sep 16 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Buy | M | 7.48 | 13,368 | 99,993 | 155,975 | 142.6 K to 156 K (+9.37 %) |
Sep 16 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 99.33 | 2,197 | 218,232 | 142,607 | 144.8 K to 142.6 K (-1.52 %) |
Sep 16 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 98.50 | 1,900 | 187,142 | 144,804 | 146.7 K to 144.8 K (-1.30 %) |
Sep 16 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 106.33 | 300 | 31,900 | 146,704 | 147 K to 146.7 K (-0.20 %) |
Sep 16 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 105.53 | 700 | 73,870 | 147,004 | 147.7 K to 147 K (-0.47 %) |
Sep 16 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 104.53 | 2,203 | 230,282 | 147,704 | 149.9 K to 147.7 K (-1.47 %) |
Sep 16 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 103.75 | 1,700 | 176,373 | 149,907 | 151.6 K to 149.9 K (-1.12 %) |
Sep 16 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 102.58 | 1,200 | 123,092 | 151,607 | 152.8 K to 151.6 K (-0.79 %) |
Sep 16 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 101.20 | 1,200 | 121,444 | 152,807 | 154 K to 152.8 K (-0.78 %) |
Sep 16 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 100.28 | 1,100 | 110,304 | 154,007 | 155.1 K to 154 K (-0.71 %) |
Sep 16 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Buy | M | 7.03 | 12,500 | 87,875 | 155,107 | 142.6 K to 155.1 K (+8.77 %) |
Sep 16 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 99.33 | 2,200 | 218,522 | 142,607 | 144.8 K to 142.6 K (-1.52 %) |
Sep 16 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 98.48 | 1,900 | 187,112 | 144,807 | 146.7 K to 144.8 K (-1.30 %) |
Sep 16 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 106.39 | 300 | 31,916 | 146,707 | 147 K to 146.7 K (-0.20 %) |
Sep 16 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 105.54 | 600 | 63,323 | 147,007 | 147.6 K to 147 K (-0.41 %) |
Sep 16 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 104.55 | 2,193 | 229,285 | 147,607 | 149.8 K to 147.6 K (-1.46 %) |
Sep 16 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 103.76 | 1,800 | 186,773 | 149,800 | 151.6 K to 149.8 K (-1.19 %) |
Sep 16 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 102.55 | 1,200 | 123,054 | 151,600 | 152.8 K to 151.6 K (-0.79 %) |
Sep 16 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 101.19 | 1,207 | 122,133 | 152,800 | 154 K to 152.8 K (-0.78 %) |
Sep 16 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 100.27 | 1,100 | 110,301 | 154,007 | 155.1 K to 154 K (-0.71 %) |
Sep 16 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Buy | M | 7.48 | 12,500 | 93,500 | 155,107 | 142.6 K to 155.1 K (+8.77 %) |
Sep 16 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 98.01 | 12,500 | 1,225,125 | 142,607 | 155.1 K to 142.6 K (-8.06 %) |
Sep 16 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Buy | M | 7.03 | 12,500 | 87,875 | 155,107 | 142.6 K to 155.1 K (+8.77 %) |
Sep 16 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 98.01 | 12,500 | 1,225,088 | 142,607 | 155.1 K to 142.6 K (-8.06 %) |
Sep 16 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Buy | M | 7.03 | 12,500 | 87,875 | 155,107 | 142.6 K to 155.1 K (+8.77 %) |
Sep 03 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Option Exercise | A | 84.68 | 3,779 | 320,006 | 3,779 | |
Sep 03 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Grant | A | 0.00 | 1,968 | 0 | 142,607 | 140.6 K to 142.6 K (+1.40 %) |
Jul 08 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Grant | A | 50.41 | 253 | 12,752 | 140,639 | 140.4 K to 140.6 K (+0.18 %) |
Mar 10 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 69.53 | 3,123 | 217,155 | 140,386 | 143.5 K to 140.4 K (-2.18 %) |
Mar 06 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | G | 21.90 | 1,644 | 36,004 | 1,644 | |
Mar 06 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | G | 21.90 | 298,386 | 6,534,653 | 298,386 | |
Mar 06 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | G | 21.90 | 300,030 | 6,570,657 | 0 | |
Mar 06 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | G | 7.15 | 219,373 | 1,568,517 | 219,373 | |
Mar 06 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | G | 7.15 | 219,373 | 1,568,517 | 0 | |
Mar 06 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | G | 21.15 | 84,483 | 1,786,815 | 84,483 | |
Mar 06 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | G | 21.15 | 84,483 | 1,786,815 | 0 | |
Mar 05 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | A | 69.37 | 46,323 | 3,213,427 | 46,323 | |
Mar 05 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Grant | A | 0.00 | 24,025 | 0 | 143,509 | 119.5 K to 143.5 K (+20.11 %) |
Mar 02 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 0.00 | 7,716 | 0 | 7,716 | |
Mar 02 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 0.00 | 7,716 | 0 | 119,484 | 111.8 K to 119.5 K (+6.90 %) |
Feb 26 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 0.00 | 43,333 | 0 | 0 | |
Feb 26 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 81.16 | 18,908 | 1,534,498 | 111,768 | 130.7 K to 111.8 K (-14.47 %) |
Feb 26 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 88.26 | 43,333 | 3,824,571 | 130,676 | 87.3 K to 130.7 K (+49.61 %) |
Jan 24 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 7.03 | 1,400 | 9,842 | 32,579 | |
Jan 24 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 7.03 | 1,515 | 10,650 | 26,933 | |
Jan 24 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 98.18 | 1,400 | 137,452 | 87,343 | 88.7 K to 87.3 K (-1.58 %) |
Jan 24 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 7.03 | 1,400 | 9,842 | 88,743 | 87.3 K to 88.7 K (+1.60 %) |
Jan 24 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 98.11 | 1,515 | 148,632 | 87,343 | 88.9 K to 87.3 K (-1.70 %) |
Jan 24 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 7.03 | 1,515 | 10,650 | 88,858 | 87.3 K to 88.9 K (+1.73 %) |
Jan 13 2020 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Grant | A | 52.58 | 164 | 8,623 | 87,343 | 87.2 K to 87.3 K (+0.19 %) |
Nov 19 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 3.44 | 5,832 | 20,062 | 0 | |
Nov 19 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 3.44 | 20,000 | 68,800 | 5,832 | |
Nov 19 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 86.93 | 900 | 78,234 | 87,179 | 88.1 K to 87.2 K (-1.02 %) |
Nov 19 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 86.08 | 3,132 | 269,603 | 88,079 | 91.2 K to 88.1 K (-3.43 %) |
Nov 19 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 85.35 | 1,800 | 153,634 | 91,211 | 93 K to 91.2 K (-1.94 %) |
Nov 19 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 3.44 | 5,832 | 20,062 | 93,011 | 87.2 K to 93 K (+6.69 %) |
Nov 19 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 84.01 | 1,439 | 120,886 | 87,179 | 88.6 K to 87.2 K (-1.62 %) |
Nov 19 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 83.52 | 12,461 | 1,040,768 | 88,618 | 101.1 K to 88.6 K (-12.33 %) |
Nov 19 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 82.53 | 6,100 | 503,439 | 101,079 | 107.2 K to 101.1 K (-5.69 %) |
Nov 19 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 3.44 | 20,000 | 68,800 | 107,179 | 87.2 K to 107.2 K (+22.94 %) |
Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 7.03 | 2,407 | 16,921 | 33,979 | |
Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 3.44 | 20,000 | 68,800 | 25,832 | |
Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 3.44 | 5,169 | 17,781 | 0 | |
Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 7.03 | 10,000 | 70,300 | 36,386 | |
Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 3.44 | 20,000 | 68,800 | 45,832 | |
Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Option Exercise | M | 3.44 | 10,000 | 34,400 | 5,169 | |
Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 82.62 | 504 | 41,642 | 87,179 | 87.7 K to 87.2 K (-0.57 %) |
Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 81.80 | 1,403 | 114,771 | 87,683 | 89.1 K to 87.7 K (-1.57 %) |
Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 80.96 | 500 | 40,478 | 89,086 | 89.6 K to 89.1 K (-0.56 %) |
Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 7.03 | 2,407 | 16,921 | 89,586 | 87.2 K to 89.6 K (+2.76 %) |
Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 82.54 | 7,200 | 594,252 | 87,179 | 94.4 K to 87.2 K (-7.63 %) |
Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 81.67 | 10,800 | 881,993 | 94,379 | 105.2 K to 94.4 K (-10.27 %) |
Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 80.78 | 2,000 | 161,556 | 105,179 | 107.2 K to 105.2 K (-1.87 %) |
Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 3.44 | 20,000 | 68,800 | 107,179 | 87.2 K to 107.2 K (+22.94 %) |
Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 82.50 | 1,764 | 145,526 | 87,179 | 88.9 K to 87.2 K (-1.98 %) |
Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 81.66 | 2,805 | 229,062 | 88,943 | 91.7 K to 88.9 K (-3.06 %) |
Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 80.68 | 600 | 48,409 | 91,748 | 92.3 K to 91.7 K (-0.65 %) |
Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 3.44 | 5,169 | 17,781 | 92,348 | 87.2 K to 92.3 K (+5.93 %) |
Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 81.16 | 2,542 | 206,304 | 87,179 | 89.7 K to 87.2 K (-2.83 %) |
Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 80.79 | 7,458 | 602,495 | 89,721 | 97.2 K to 89.7 K (-7.67 %) |
Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 7.03 | 10,000 | 70,300 | 97,179 | 87.2 K to 97.2 K (+11.47 %) |
Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 81.13 | 6,332 | 513,684 | 87,179 | 93.5 K to 87.2 K (-6.77 %) |
Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 80.72 | 13,668 | 1,103,240 | 93,511 | 107.2 K to 93.5 K (-12.75 %) |
Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 3.44 | 20,000 | 68,800 | 107,179 | 87.2 K to 107.2 K (+22.94 %) |
Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 81.16 | 2,458 | 199,486 | 87,179 | 89.6 K to 87.2 K (-2.74 %) |
Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Sell | S | 80.80 | 7,542 | 609,409 | 89,637 | 97.2 K to 89.6 K (-7.76 %) |
Nov 15 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Financial Off ... | Buy | M | 3.44 | 10,000 | 34,400 | 97,179 | 87.2 K to 97.2 K (+11.47 %) |
Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Option Exercise | M | 7.03 | 1,961 | 13,786 | 58,286 | |
Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Option Exercise | M | 7.03 | 1,961 | 13,786 | 58,286 | |
Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Option Exercise | M | 3.44 | 4,031 | 13,867 | 90,632 | |
Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Option Exercise | M | 3.44 | 4,031 | 13,867 | 90,632 | |
Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Option Exercise | M | 3.44 | 2,000 | 6,880 | 27,069 | |
Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Option Exercise | M | 3.44 | 2,000 | 6,880 | 27,069 | |
Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Sell | S | 81.19 | 300 | 24,358 | 87,179 | 87.5 K to 87.2 K (-0.34 %) |
Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Sell | S | 81.19 | 300 | 24,358 | 87,179 | 87.5 K to 87.2 K (-0.34 %) |
Sep 26 2019 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | CFO | Sell | S | 80.56 | 1,661 | 133,804 | 87,479 | 89.1 K to 87.5 K (-1.86 %) |